February 12, 2018 / 12:13 PM / 9 days ago

BRIEF-Akebia Therapeutics Gives Update On Vadadustat Development Program

Feb 12 (Reuters) - Akebia Therapeutics Inc:

* AKEBIA THERAPEUTICS PROVIDES UPDATE ON VADADUSTAT DEVELOPMENT PROGRAM

* AKEBIA THERAPEUTICS INC - TARGETS FULL ENROLLMENT FOR INNO(2)VATE AND PRO(2)TECT BY END OF 2018

* AKEBIA THERAPEUTICS INC - CONFIRMS EXPECTATION OF TOP-LINE RESULTS FOR INNO(2)VATE & PRO(2)TECT IN 2019, SUBJECT TO ACCRUAL OF MACE EVENTS

* AKEBIA THERAPEUTICS INC - PARTNER MITSUBISHI TANABE PHARMA CORP INITIATES PHASE 3 NDD-CKD AND DD-CKD PROGRAM IN JAPAN Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below